AN2 Therapeutics, Inc. (ANTX)

NASDAQ: ANTX · IEX Real-Time Price · USD
8.31
+0.15 (1.84%)
Jul 5, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Selling, General & Admin
4.671.27
Research & Development
16.916.02
Other Operating Expenses
0.046.32
Operating Expenses
21.6113.61
Operating Income
-21.61-13.61
Other Expense / Income
-0.07-0
Pretax Income
-21.54-13.6
Net Income
-21.54-13.6
Preferred Dividends
6.520.98
Net Income Common
-28.06-14.58
Shares Outstanding (Basic)
33
Shares Outstanding (Diluted)
33
Shares Change
2.71%-
EPS (Basic)
-10.64-5.68
EPS (Diluted)
-10.64-5.68
Free Cash Flow Per Share
-7.76-2.09
EBITDA
-21.54-13.6
EBIT
-21.54-13.6
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).